Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries
Kaiming Wang, Mahmoud Gheblawi, Anish Nikhanj, et al.
Hypertension (2021) Vol. 79, Iss. 2, pp. 365-378
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID
Kaiming Wang, Mobin Khoramjoo, Karthik K. Srinivasan, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101254-101254
Open Access | Times Cited: 21
Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation
Anthony J. Turner, Natalia N. Nalivaeva
Peptides (2022) Vol. 151, pp. 170766-170766
Open Access | Times Cited: 31
Kidney Injury in COVID-19: Epidemiology, Molecular Mechanisms and Potential Therapeutic Targets
J. Pedro Teixeira, Sharon Barone, Kamyar Zahedi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2242-2242
Open Access | Times Cited: 27
Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment
Mark C. Chappell
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1320-1337
Open Access | Times Cited: 17
P38 MAPK activated ADAM17 mediates ACE2 shedding and promotes cardiac remodeling and heart failure after myocardial infarction
Qi Chen, Yilan Li, Bike Bie, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations
Lucia A. Méndez‐García, Galileo Escobedo, Alan Gerardo Minguer-Uribe, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 24
The systemic renin-angiotensin system in COVID-19
Roman Reindl‐Schwaighofer, Sebastian Hödlmoser, Oliver Domenig, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
The classical and alternative circulating renin‐angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease
Hillary K. Hammond, Marisa K. Ames, Oliver Domenig, et al.
Journal of Veterinary Internal Medicine (2023) Vol. 37, Iss. 3, pp. 875-886
Open Access | Times Cited: 12
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Laure‐Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4464-4464
Open Access | Times Cited: 21
The Renin–Angiotensin System (RAS) in COVID-19 Disease: Where We Are 3 Years after the Beginning of the Pandemic
Marco Prato, Natalia Tiberti, Cristina Mazzi, et al.
Microorganisms (2024) Vol. 12, Iss. 3, pp. 583-583
Open Access | Times Cited: 3
Effects of Losartan on Patients Hospitalized for Acute Coronavirus Disease 2019: A Randomized Controlled Trial
Karen Tran, Pierre Asfar, Matthew P. Cheng, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 3, pp. 615-625
Closed Access | Times Cited: 3
Urinary angiotensin-converting enzyme 2 and metabolomics in COVID-19-mediated kidney injury
Ander Vergara, Kaiming Wang, Daniele Colombo, et al.
Clinical Kidney Journal (2022) Vol. 16, Iss. 2, pp. 272-284
Open Access | Times Cited: 17
ACE2 Expression in Organotypic Human Airway Epithelial Cultures and Airway Biopsies
Qianyu Chen, Shenna Langenbach, Meina Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
SARS-CoV-2 infection downregulates myocardial ACE2 and potentiates cardiac inflammation in humans and hamsters
Anissa Viveiros, Ryan S. Noyce, Mahmoud Gheblawi, et al.
AJP Heart and Circulatory Physiology (2022) Vol. 323, Iss. 6, pp. H1262-H1269
Open Access | Times Cited: 15
Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic
Hongyin Chen, Jiangyun Peng, Tengyao Wang, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115370-115370
Open Access | Times Cited: 14
New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System
G. Sansoè, Manuela Aragno
Journal of the Renin-Angiotensin-Aldosterone System (2023) Vol. 2023
Open Access | Times Cited: 8
Plasma taurine level is linked to symptom burden and clinical outcomes in post-COVID condition
Mobin Khoramjoo, Kaiming Wang, Karthik K. Srinivasan, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0304522-e0304522
Open Access | Times Cited: 2
Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2
Noelia Díaz-Troyano, Pablo Gabriel-Medina, Stephen G. Weber, et al.
Diagnostics (2022) Vol. 12, Iss. 4, pp. 886-886
Open Access | Times Cited: 11
SARS-CoV-2-Induced Myocarditis: A State-of-the-Art Review
Francesco Nappi, Sanjeet Singh
Viruses (2023) Vol. 15, Iss. 4, pp. 916-916
Open Access | Times Cited: 6
The Renin-Angiotensin System as a Component of Biotrauma in Acute Respiratory Distress Syndrome
Katharina Krenn, Verena Tretter, Felix Kraft, et al.
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 10
The prognostic importance of the angiotensin II/angiotensin-(1–7) ratio in patients with SARS-CoV-2 infection
Luís M. Amezcua‐Guerra, Leonardo del Valle‐Mondragón, Héctor González‐Pacheco, et al.
Therapeutic Advances in Respiratory Disease (2022) Vol. 16
Open Access | Times Cited: 10
Understanding COVID-19-associated endothelial dysfunction: role of PIEZO1 as a potential therapeutic target
Xiaoting Zhang, Jinhai Liu, Xiaoming Deng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19
Jiangming Sun, Andreas Edsfeldt, Joel Svensson, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5911-5911
Open Access | Times Cited: 1
Food-Derived Up-Regulators and Activators of Angiotensin Converting Enzyme 2: A Review
Z. Wang, Hongbing Fan, Jianping Wu
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 23, pp. 12896-12914
Open Access | Times Cited: 1
Safety and Feasibility of Third-Party Cytotoxic T Lymphocytes for High-Risk Patients with Covid-19
Dolores Grosso, John L. Wagner, Allyson O’Connor, et al.
Blood Advances (2024) Vol. 8, Iss. 15, pp. 4113-4124
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top